Related Experiment Video
Updated: Apr 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach
An S De Vriese1, Sanjeev Sethi2, Jens Van Praet3
1Division of Nephrology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium; and an.devriese@azsintjan.be.
Insights
Kidney diseases linked to complement alternative pathway (AP) dysregulation should be classified by cause, not symptoms. Understanding the specific AP dysfunction is crucial for effective treatment and predicting patient outcomes.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- Kidney diseases from complement alternative pathway (AP) dysregulation are currently classified by clinical presentation, biopsy, or course.
- These disorders share a common feature of inappropriate AP activation leading to renal damage.
- Clinical diversity masks underlying etiologic differences.
Purpose of the Study:
- To propose a unified classification of AP-related kidney diseases based on etiology.
- To define pathophysiologic categories of AP dysfunction.
- To highlight the importance of precise diagnosis for guiding treatment and predicting outcomes.
Main Methods:
- Review of existing literature on AP-related kidney diseases.
- Analysis of clinical, pathological, and genetic data.
- Categorization of AP dysfunctions based on underlying pathogenesis.
Main Results:
- The study identifies distinct pathophysiologic categories of AP dysfunction.
- It emphasizes that clinical presentation, biopsy, and course are variable manifestations of underlying AP dysregulation.
- Accurate etiologic identification is key to predicting treatment response and transplant outcomes.
Conclusions:
- Kidney diseases caused by AP dysregulation should be classified etiologically.
- Precise identification of the underlying AP abnormality is essential for personalized treatment strategies.
- Multidisciplinary collaboration is vital for diagnosing and managing these complex kidney diseases.
Abstract:
Kidney diseases caused by genetic or acquired dysregulation of the complement alternative pathway (AP) are traditionally classified on the basis of clinical presentation (atypical hemolytic uremic syndrome as thrombotic microangiopathy), biopsy appearance (dense deposit disease and C3 GN), or clinical course (atypical postinfectious GN). Each is characterized by an inappropriate activation of the AP, eventuating in renal damage. The clinical diversity of these disorders highlights important differences in the triggers, the sites and intensity of involvement, and the outcome of the AP dysregulation. Nevertheless, we contend that these diseases should be grouped as disorders of the AP and classified on an etiologic basis. In this review, we define different pathophysiologic categories of AP dysfunction. The precise identification of the underlying abnormality is the key to predict the response to immune suppression, plasma infusion, and complement-inhibitory drugs and the outcome after transplantation. In a patient with presumed dysregulation of the AP, the collaboration of the clinician, the renal pathologist, and the biochemical and genetic laboratory is very much encouraged, because this enables the elucidation of both the underlying pathogenesis and the optimal therapeutic approach.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Complement System

